207 related articles for article (PubMed ID: 27484786)
21. Assessment of human Nter and Cter BRCA1 mutations using growth and localization assays in yeast.
Millot GA; Berger A; Lejour V; Boulé JB; Bobo C; Cullin C; Lopes J; Stoppa-Lyonnet D; Nicolas A
Hum Mutat; 2011 Dec; 32(12):1470-80. PubMed ID: 21922593
[TBL] [Abstract][Full Text] [Related]
22. The repair of DNA methylation damage in Saccharomyces cerevisiae.
Xiao W; Chow BL; Rathgeber L
Curr Genet; 1996 Dec; 30(6):461-8. PubMed ID: 8939806
[TBL] [Abstract][Full Text] [Related]
23. Functional Validation of Rare Human Genetic Variants Involved in Homologous Recombination Using Saccharomyces cerevisiae.
Lee MS; Yu M; Kim KY; Park GH; Kwack K; Kim KP
PLoS One; 2015; 10(5):e0124152. PubMed ID: 25938495
[TBL] [Abstract][Full Text] [Related]
24. Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach.
Tischkowitz M; Hamel N; Carvalho MA; Birrane G; Soni A; van Beers EH; Joosse SA; Wong N; Novak D; Quenneville LA; Grist SA; ; Nederlof PM; Goldgar DE; Tavtigian SV; Monteiro AN; Ladias JA; Foulkes WD
Eur J Hum Genet; 2008 Jul; 16(7):820-32. PubMed ID: 18285836
[TBL] [Abstract][Full Text] [Related]
25. Identifying the effects of BRCA1 mutations on homologous recombination using cells that express endogenous wild-type BRCA1.
Parvin J; Chiba N; Ransburgh D
J Vis Exp; 2011 Feb; (48):. PubMed ID: 21372787
[TBL] [Abstract][Full Text] [Related]
26. Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance.
Langerud J; Jarhelle E; Van Ghelue M; Ariansen SL; Iversen N
Hum Genomics; 2018 Nov; 12(1):51. PubMed ID: 30458859
[TBL] [Abstract][Full Text] [Related]
27. Functional analyses of rare germline BRCA1 variants by transcriptional activation and homologous recombination repair assays.
Bassi N; Hovland HN; Rasheed K; Jarhelle E; Pedersen N; Mchaina EK; Bakkan SME; Iversen N; Høberg-Vetti H; Haukanes BI; Knappskog PM; Aukrust I; Ognedal E; Van Ghelue M
BMC Cancer; 2023 Apr; 23(1):368. PubMed ID: 37085799
[TBL] [Abstract][Full Text] [Related]
28. Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance.
Anantha RW; Simhadri S; Foo TK; Miao S; Liu J; Shen Z; Ganesan S; Xia B
Elife; 2017 Apr; 6():. PubMed ID: 28398198
[TBL] [Abstract][Full Text] [Related]
29. Genetic effects of methylmethanesulphonate during meiosis in Saccharomyces cerevisiae.
Kelly SL; Parry JM
Mutagenesis; 1986 Mar; 1(2):151-5. PubMed ID: 3333271
[TBL] [Abstract][Full Text] [Related]
30. Multiple recombination pathways for sister chromatid exchange in Saccharomyces cerevisiae: role of RAD1 and the RAD52 epistasis group genes.
Dong Z; Fasullo M
Nucleic Acids Res; 2003 May; 31(10):2576-85. PubMed ID: 12736307
[TBL] [Abstract][Full Text] [Related]
31. Repair of MMS-induced DNA double-strand breaks in haploid cells of Saccharomyces cerevisiae, which requires the presence of a duplicate genome.
Chlebowicz E; Jachymczyk WJ
Mol Gen Genet; 1979 Jan; 167(3):279-86. PubMed ID: 368592
[TBL] [Abstract][Full Text] [Related]
32. Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.
Foo TK; Tischkowitz M; Simhadri S; Boshari T; Zayed N; Burke KA; Berman SH; Blecua P; Riaz N; Huo Y; Ding YC; Neuhausen SL; Weigelt B; Reis-Filho JS; Foulkes WD; Xia B
Oncogene; 2017 Jul; 36(29):4161-4170. PubMed ID: 28319063
[TBL] [Abstract][Full Text] [Related]
33. Dpb11, the budding yeast homolog of TopBP1, functions with the checkpoint clamp in recombination repair.
Ogiwara H; Ui A; Onoda F; Tada S; Enomoto T; Seki M
Nucleic Acids Res; 2006; 34(11):3389-98. PubMed ID: 16840526
[TBL] [Abstract][Full Text] [Related]
34. The N-terminal region of Sgs1, which interacts with Top3, is required for complementation of MMS sensitivity and suppression of hyper-recombination in sgs1 disruptants.
Ui A; Satoh Y; Onoda F; Miyajima A; Seki M; Enomoto T
Mol Genet Genomics; 2001 Jul; 265(5):837-50. PubMed ID: 11523801
[TBL] [Abstract][Full Text] [Related]
35. Inducibility of gene conversion in Saccharomyces cerevisiae treated with MMS.
Cundari E; Vellosi R; Galli A; Bronzetti G
Mutat Res; 1986 Aug; 174(4):271-4. PubMed ID: 3526142
[TBL] [Abstract][Full Text] [Related]
36. Yeast screens identify the RNA polymerase II CTD and SPT5 as relevant targets of BRCA1 interaction.
Bennett CB; Westmoreland TJ; Verrier CS; Blanchette CA; Sabin TL; Phatnani HP; Mishina YV; Huper G; Selim AL; Madison ER; Bailey DD; Falae AI; Galli A; Olson JA; Greenleaf AL; Marks JR
PLoS One; 2008 Jan; 3(1):e1448. PubMed ID: 18197258
[TBL] [Abstract][Full Text] [Related]
37. Identification of a RING protein that can interact in vivo with the BRCA1 gene product.
Wu LC; Wang ZW; Tsan JT; Spillman MA; Phung A; Xu XL; Yang MC; Hwang LY; Bowcock AM; Baer R
Nat Genet; 1996 Dec; 14(4):430-40. PubMed ID: 8944023
[TBL] [Abstract][Full Text] [Related]
38. Identification of two novel BRCA1-partner genes in the DNA double-strand break repair pathway.
Guglielmi C; Cerri I; Evangelista M; Collavoli A; Tancredi M; Aretini P; Caligo MA
Breast Cancer Res Treat; 2013 Oct; 141(3):515-22. PubMed ID: 24104880
[TBL] [Abstract][Full Text] [Related]
39. Cytoplasmic mislocalization of BRCA1 caused by cancer-associated mutations in the BRCT domain.
Rodriguez JA; Au WW; Henderson BR
Exp Cell Res; 2004 Feb; 293(1):14-21. PubMed ID: 14729053
[TBL] [Abstract][Full Text] [Related]
40. BRCA1 interacts with dominant negative SWI/SNF enzymes without affecting homologous recombination or radiation-induced gene activation of p21 or Mdm2.
Hill DA; de la Serna IL; Veal TM; Imbalzano AN
J Cell Biochem; 2004 Apr; 91(5):987-98. PubMed ID: 15034933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
